(STI) Solidion Technology - Ratings and Ratios
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8342121022
Anode Materials, All-Solid-State Cells, Anodeless Lithium Cells, Lithium-Sulfur Cells
Description: STI Solidion Technology October 20, 2025
Solidion Technology, Inc. (NASDAQ: STI) develops and commercializes next-generation battery materials and cell technologies, including advanced silicon-rich anodes, all-solid-state lithium-ion cells, anode-less lithium-metal cells, and lithium-sulfur cells. The firm operates as a subsidiary of Global Graphene Group and is headquartered in Dallas, Texas.
STI trades as a common stock under the ticker “STI,” is incorporated in the United States, and is classified in the GICS sub-industry “Electrical Components & Equipment.”
Key industry context: the global solid-state battery market is projected to grow at a CAGR of roughly 30 % from 2024-2030, driven by rising EV adoption and government incentives for higher-energy-density storage. Solidion disclosed a $55 million Series A financing round in 2023 and announced a pilot production line capable of 100 kWh per month, positioning it to capture early-stage demand. However, the company’s commercial scale-up risk remains high, as demonstrated-volume manufacturing for solid-state chemistries is still nascent and capital-intensive.
For a deeper quantitative assessment of STI’s valuation relative to peers, the ValueRay platform offers a data-rich dashboard worth exploring.
STI Stock Overview
| Market Cap in USD | 92m |
| Sub-Industry | Electrical Components & Equipment |
| IPO / Inception | 2024-02-02 |
STI Stock Ratings
| Growth Rating | -84.0% |
| Fundamental | 35.3% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -38.8% |
| Analyst Rating | - |
STI Dividends
Currently no dividends paidSTI Growth Ratios
| Growth Correlation 3m | 82.5% |
| Growth Correlation 12m | -59.6% |
| Growth Correlation 5y | -87.6% |
| CAGR 5y | -72.35% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.73 |
| CAGR/Mean DD 3y (Pain Ratio) | -1.23 |
| Sharpe Ratio 12m | -0.88 |
| Alpha | -50.78 |
| Beta | 0.435 |
| Volatility | 212.51% |
| Current Volume | 112.6k |
| Average Volume 20d | 448k |
| Stop Loss | 11 (-7.3%) |
| Signal | -0.56 |
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income (-8.84m TTM) > 0 and > 6% of Revenue (6% = 23.9k TTM) |
| FCFTA -1.38 (>2.0%) and ΔFCFTA -75.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -398.4% (prev -347.2k%; Δ 346.8kpp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -1.33 (>3.0%) and CFO -7.09m > Net Income -8.84m (YES >=105%, WARN >=100%) |
| Net Debt (1.76m) to EBITDA (3.19m) ratio: 0.55 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (3.20m) change vs 12m ago 66.25% (target <= -2.0% for YES) |
| Gross Margin 56.41% (prev -8449 %; Δ 8505 pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 6.67% (prev 0.10%; Δ 6.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.95 (EBITDA TTM 3.19m / Interest Expense TTM 562.9k) >= 6 (WARN >= 3) |
Altman Z'' -72.97
| (A) -0.30 = (Total Current Assets 1.22m - Total Current Liabilities 2.81m) / Total Assets 5.33m |
| (B) -19.97 = Retained Earnings (Balance) -106.5m / Total Assets 5.33m |
| warn (B) unusual magnitude: -19.97 — check mapping/units |
| (C) 0.09 = EBIT TTM 532.7k / Avg Total Assets 5.98m |
| (D) -6.21 = Book Value of Equity -106.5m / Total Liabilities 17.2m |
| Total Rating: -72.97 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 35.33
| 1. Piotroski 2.0pt = -3.0 |
| 2. FCF Yield -7.87% = -3.94 |
| 3. FCF Margin data missing |
| 4. Debt/Equity -0.16 = -2.50 |
| 5. Debt/Ebitda 0.55 = 2.27 |
| 6. ROIC - WACC (= -11.32)% = -12.50 |
| 7. RoE 53.81% = 2.50 |
| 8. Rev. Trend 40.90% = 3.07 |
| 9. EPS Trend -11.38% = -0.57 |
What is the price of STI shares?
As of November 09, 2025, the stock is trading at USD 11.86 with a total of 112,638 shares traded.
Over the past week, the price has changed by -6.25%, over one month by +143.53%, over three months by +251.93% and over the past year by -30.24%.
Over the past week, the price has changed by -6.25%, over one month by +143.53%, over three months by +251.93% and over the past year by -30.24%.
Is Solidion Technology a good stock to buy?
No, based on ValueRay´s Fundamental Analyses, Solidion Technology (NASDAQ:STI) is currently (November 2025)
a stock to sell. It has a ValueRay Fundamental Rating of 35.33 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of STI is around 8.88 USD . This means that STI is currently overvalued and has a potential downside of -25.13%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of STI is around 8.88 USD . This means that STI is currently overvalued and has a potential downside of -25.13%.
Is STI a buy, sell or hold?
Solidion Technology has no consensus analysts rating.
What are the forecasts/targets for the STI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 71.5 | 502.9% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 9.8 | -17.2% |
STI Fundamental Data Overview November 04, 2025
Market Cap USD = 91.7m (91.7m USD * 1.0 USD.USD)
P/S = 22936.736
P/B = 663973.3535
Beta = 0.435
Revenue TTM = 398.6k USD
EBIT TTM = 532.7k USD
EBITDA TTM = 3.19m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 1.88m USD (from shortTermDebt, last quarter)
Debt = 1.88m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.76m USD (from netDebt column, last quarter)
Enterprise Value = 93.5m USD (91.7m + Debt 1.88m - CCE 114.7k)
Interest Coverage Ratio = 0.95 (Ebit TTM 532.7k / Interest Expense TTM 562.9k)
FCF Yield = -7.87% (FCF TTM -7.36m / Enterprise Value 93.5m)
FCF Margin = -1847 % (FCF TTM -7.36m / Revenue TTM 398.6k)
Net Margin = -2218 % (Net Income TTM -8.84m / Revenue TTM 398.6k)
Gross Margin = 56.41% ((Revenue TTM 398.6k - Cost of Revenue TTM 173.8k) / Revenue TTM)
Gross Margin QoQ = 41.83% (prev 82.28%)
Tobins Q-Ratio = 17.53 (Enterprise Value 93.5m / Total Assets 5.33m)
Interest Expense / Debt = 6.00% (Interest Expense 112.5k / Debt 1.88m)
Taxrate = 0.0% (0.0 / 146.8k)
NOPAT = 532.7k (EBIT 532.7k * (1 - 0.00%))
Current Ratio = 0.44 (Total Current Assets 1.22m / Total Current Liabilities 2.81m)
Debt / Equity = -0.16 (negative equity) (Debt 1.88m / totalStockholderEquity, last quarter -11.8m)
Debt / EBITDA = 0.55 (Net Debt 1.76m / EBITDA 3.19m)
Debt / FCF = -0.24 (negative FCF - burning cash) (Net Debt 1.76m / FCF TTM -7.36m)
Total Stockholder Equity = -16.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -165.7% (out of range, set to none)
RoE = 53.81% (negative equity) (Net Income TTM -8.84m / Total Stockholder Equity -16.4m)
RoCE = -3.24% (negative capital employed) (EBIT 532.7k / Capital Employed (Equity -16.4m + L.T.Debt 0.0))
RoIC = -3.74% (NOPAT 532.7k / Invested Capital -14.3m)
WACC = 7.59% (E(91.7m)/V(93.6m) * Re(7.62%) + D(1.88m)/V(93.6m) * Rd(6.00%) * (1-Tc(0.0)))
Discount Rate = 7.62% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 47.77%
Fair Price DCF = unknown (Cash Flow -7.36m)
EPS Correlation: -11.38 | EPS CAGR: 79.54% | SUE: N/A | # QB: 0
Revenue Correlation: 40.90 | Revenue CAGR: 216.2% | SUE: N/A | # QB: 0
P/S = 22936.736
P/B = 663973.3535
Beta = 0.435
Revenue TTM = 398.6k USD
EBIT TTM = 532.7k USD
EBITDA TTM = 3.19m USD
Long Term Debt = unknown (0.0)
Short Term Debt = 1.88m USD (from shortTermDebt, last quarter)
Debt = 1.88m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.76m USD (from netDebt column, last quarter)
Enterprise Value = 93.5m USD (91.7m + Debt 1.88m - CCE 114.7k)
Interest Coverage Ratio = 0.95 (Ebit TTM 532.7k / Interest Expense TTM 562.9k)
FCF Yield = -7.87% (FCF TTM -7.36m / Enterprise Value 93.5m)
FCF Margin = -1847 % (FCF TTM -7.36m / Revenue TTM 398.6k)
Net Margin = -2218 % (Net Income TTM -8.84m / Revenue TTM 398.6k)
Gross Margin = 56.41% ((Revenue TTM 398.6k - Cost of Revenue TTM 173.8k) / Revenue TTM)
Gross Margin QoQ = 41.83% (prev 82.28%)
Tobins Q-Ratio = 17.53 (Enterprise Value 93.5m / Total Assets 5.33m)
Interest Expense / Debt = 6.00% (Interest Expense 112.5k / Debt 1.88m)
Taxrate = 0.0% (0.0 / 146.8k)
NOPAT = 532.7k (EBIT 532.7k * (1 - 0.00%))
Current Ratio = 0.44 (Total Current Assets 1.22m / Total Current Liabilities 2.81m)
Debt / Equity = -0.16 (negative equity) (Debt 1.88m / totalStockholderEquity, last quarter -11.8m)
Debt / EBITDA = 0.55 (Net Debt 1.76m / EBITDA 3.19m)
Debt / FCF = -0.24 (negative FCF - burning cash) (Net Debt 1.76m / FCF TTM -7.36m)
Total Stockholder Equity = -16.4m (last 4 quarters mean from totalStockholderEquity)
RoA = -165.7% (out of range, set to none)
RoE = 53.81% (negative equity) (Net Income TTM -8.84m / Total Stockholder Equity -16.4m)
RoCE = -3.24% (negative capital employed) (EBIT 532.7k / Capital Employed (Equity -16.4m + L.T.Debt 0.0))
RoIC = -3.74% (NOPAT 532.7k / Invested Capital -14.3m)
WACC = 7.59% (E(91.7m)/V(93.6m) * Re(7.62%) + D(1.88m)/V(93.6m) * Rd(6.00%) * (1-Tc(0.0)))
Discount Rate = 7.62% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 47.77%
Fair Price DCF = unknown (Cash Flow -7.36m)
EPS Correlation: -11.38 | EPS CAGR: 79.54% | SUE: N/A | # QB: 0
Revenue Correlation: 40.90 | Revenue CAGR: 216.2% | SUE: N/A | # QB: 0
Additional Sources for STI Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle